Literature DB >> 32242150

ASPI: a public-private partnership to develop treatments for autism.

Seth Ness, Gahan Pandina, Shyla Jagannatha, Kyle Wathen, Abigail Bangerter, Nikolay V Manyakov, Robert Hendren, Bennett Leventhal, Declan Murphy, Geraldine Dawson, Wayne C Drevets, Husseini K Manji.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32242150     DOI： 10.1038/d41573-020-00012-4

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  3 in total

1.  The platform trial: an efficient strategy for evaluating multiple treatments.

Authors:  Scott M Berry; Jason T Connor; Roger J Lewis
Journal:  JAMA       Date:  2015-04-28       Impact factor: 56.272

2.  The Autism Impact Measure (AIM): initial development of a new tool for treatment outcome measurement.

Authors:  Stephen M Kanne; Micah O Mazurek; Darryn Sikora; Jayne Bellando; Lee Branum-Martin; Benjamin Handen; Terry Katz; Brian Freedman; Mary Paige Powell; Zachary Warren
Journal:  J Autism Dev Disord       Date:  2014-01

3.  An Observational Study With the Janssen Autism Knowledge Engine (JAKE®) in Individuals With Autism Spectrum Disorder.

Authors:  Seth L Ness; Abigail Bangerter; Nikolay V Manyakov; David Lewin; Matthew Boice; Andrew Skalkin; Shyla Jagannatha; Meenakshi Chatterjee; Geraldine Dawson; Matthew S Goodwin; Robert Hendren; Bennett Leventhal; Frederick Shic; Jean A Frazier; Yvette Janvier; Bryan H King; Judith S Miller; Christopher J Smith; Russell H Tobe; Gahan Pandina
Journal:  Front Neurosci       Date:  2019-02-27       Impact factor: 4.677
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.